β2-Adrenoceptor agonists in the regulation of mitochondrial biogenesis

Bioorg Med Chem Lett. 2013 Oct 1;23(19):5376-81. doi: 10.1016/j.bmcl.2013.07.052. Epub 2013 Jul 31.

Abstract

The stimulation of mitochondrial biogenesis (MB) via cell surface G-protein coupled receptors is a promising strategy for cell repair and regeneration. Here we report the specificity and chemical rationale of a panel of β2-adrenoceptor agonists with regards to MB. Using primary cultures of renal cells, a diverse panel of β2-adrenoceptor agonists elicited three distinct phenotypes: full MB, partial MB, and non-MB. Full MB compounds had efficacy in the low nanomolar range and represent two chemical scaffolds containing three distinct chemical clusters. Interestingly, the MB phenotype did not correlate with reported receptor affinity or chemical similarity. Chemical clusters were then subjected to pharmacophore modeling creating two models with unique and distinct features, consisting of five conserved amongst full MB compounds were identified. The two discrete pharmacophore models were coalesced into a consensus pharmacophore with four unique features elucidating the spatial and chemical characteristics required to stimulate MB.

Keywords: Adrenoceptor; Biogenesis; Chemical similarity; Clustering; Mitochondria; Pharmacophore; Renal.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adrenergic beta-2 Receptor Agonists / chemistry
  • Adrenergic beta-2 Receptor Agonists / pharmacology*
  • Aniline Compounds / chemistry
  • Aniline Compounds / pharmacology
  • Cells, Cultured
  • Humans
  • Mitochondria / drug effects*
  • Models, Molecular
  • Molecular Structure
  • Phenotype

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Aniline Compounds